GSTM1 and hematologic disorder: Similarly, subjects with both null GSTT1 and GSTM1 had a significantly higher risk for hematological disorders as compared to subjects with positive GSTT1 and GSTM1 genotypes (OR 2.35, 95% CI 1.14–4.8).